A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. The company's lead candidate, ATTO-1310, targets interleukin-31 (IL-31), known as the 'itch cytokine,' for the treatment of chronic pruritic diseases including atopic dermatitis. Its pipeline also includes multi-specific candidates for other inflammatory diseases.
收盘时
US$15.60
+US$0.33 · +2.16%
盘中时间采用ET。市场数据可能有所延迟。
A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. The company's lead candidate, ATTO-1310, targets interleukin-31 (IL-31), known as the 'itch cytokine,' for the treatment of chronic pruritic diseases including atopic dermatitis. Its pipeline also includes multi-specific candidates for other inflammatory diseases.
日内区间
当前US$15.60
52周区间
当前US$15.60
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 |
|---|---|---|
| 营收 | 135万 USD | — |
| 销货成本 | 80.4万 USD | 31.3万 USD |
| 毛利 | 54.6万 USD | −31.3万 USD |
| 研究与开发 | 5415.3万 USD | 3386.4万 USD |
| 销售、一般及管理费用 | 1355.2万 USD | 737.6万 USD |
| 营业费用 | 6770.5万 USD | 4124万 USD |
| 利息收入 | 662.7万 USD | 343.7万 USD |
| 折旧和摊销 | 80.4万 USD | 31.3万 USD |
| 营业利润 | −6715.9万 USD | −4155.3万 USD |
| 净利润 | −6062.7万 USD | −3980.1万 USD |
公司数据更新于 2026年11月4日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$45.33
上涨空间 190.58%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI973.16万0.00%6892亿 USD0.03%US$376.92+1.54%
Vanguard Extended Market ETFVXF333.84万0.00%302亿 USD0.05%US$233.44+0.77%
Schwab U.S. Small-Cap ETFSCHA137.25万0.01%221.16亿 USD0.03%US$33.59+1.39%
Vanguard Russell 2000 ETFVTWO30.51万0.00%166亿 USD0.06%US$114.65+1.46%
Schwab U.S. Broad Market ETFSCHB17.22万0.00%442.08亿 USD0.03%US$29.48+1.52%
Vanguard Russell 2000 Growth ETFVTWG3.05万0.00%14亿 USD0.06%US$260.31+1.27%
Vanguard Russell 2000 Value ETFVTWV1.11万0.00%13亿 USD0.06%US$192.85+1.77%
Vanguard Russell 3000 ETFVTHR4507.820.00%49亿 USD0.06%US$337.75+1.55%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFSchwab U.S. Small-Cap ETFSCHAVanguard Russell 2000 ETFVTWOSchwab U.S. Broad Market ETFSCHBVanguard Russell 2000 Growth ETFVTWGVanguard Russell 2000 Value ETFVTWVVanguard Russell 3000 ETFVTHRAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
